Latest alternative data set from S&P Global unlocks global supply chain connections in generic drug manufacturers with robust linking capabilities
New York, Jan. 14 2019 — S&P Global Market Intelligence announced today the introduction of new alternative data set through its data feed management system, Xpressfeed™. This pharmaceutical package is a curated, sector-specific data feed which maps Panjiva supply chain data to the Food and Drug Administration’s (FDA) Orange Book. This solution allows users to monitor and track pharmaceutical shipments to generic drug manufacturers leading up to official FDA announcements.
“This Panjiva Pharmaceutical data package is the foundation for benchmarking industry activity and providing insight into market changes, market entry, patent challenges, and inventory activities of generic drug manufacturers. The latest addition demonstrates our continuous commitment to bringing transparency to global supply chains,” said Josh Green, co-founder of Panjiva.
Warren Breakstone, Managing Director and Chief Product Officer for Data Management Solutions at S&P Global Market Intelligence added, “This new source of alternative data offered via Xpressfeed provides new insights to investors and decision makers. Changes in shipment behaviour is a potential indication of FDA approval for generic distribution of drugs coming off patent and an important investment signal.”
Client use cases for this data are highlighted in the Panjiva Daily, a curated newsletter available to all clients that offers insights into supply chain trends ranging from policy impact, logistics, and industrial aspects.
Panjiva’s supply chain data was integrated to Xpressfeed in September of 2018. The latest pharmaceutical data set further complements S&P Global’s supply chain capabilities, offering clients a collection of essential intelligence to understand global company relationships.
To learn more about Xpressfeed and the new product rollouts, please click here.
About S&P Global Market Intelligence
At S&P Global Market Intelligence, we know that not all information is important—some of it is vital. We integrate financial and industry data, research and news into tools that help track performance, generate alpha, identify investment ideas, understand competitive and industry dynamics, perform valuations and assess credit risk. Investment professionals, government agencies, corporations and universities globally can gain the intelligence essential to making business and financial decisions with conviction.
S&P Global Market Intelligence is a division of S&P Global (NYSE: SPGI). For more information, visit www.spglobal.com.